Ethical issues concerning therapeutic studies in inflammatory bowel disease

Area of Science:

• Gastroenterology
• Clinical Ethics
• Medical Research

Background:

• Physicians managing Inflammatory Bowel Disease (IBD) often extend roles beyond direct medical care.
• These extended roles include patient advocacy with non-medical entities like insurers and employers.
• Patient advocacy complicates the physician-patient relationship and introduces ethical considerations, especially in clinical trials.

Purpose of the Study:

• To examine the ethical issues faced by IBD physicians involved in clinical treatment trials.
• To identify potential conflicts of interest and ethical dilemmas arising from dual roles.
• To propose measures ensuring ethical patient treatment in IBD research.

Main Methods:

• Review of ethical considerations in IBD patient care and clinical research.
• Analysis of potential conflicts of interest for clinician investigators.
• Discussion of strategies to separate clinical care from research participation.

Main Results:

• Ethical issues such as therapeutic misconception and clinical equipoise are heightened.
• Financial and non-financial conflicts of interest pose significant challenges.
• Clear delineation between clinical care and research participation is essential.

Conclusions:

• Physicians must implement measures to ensure ethical patient conduct in IBD clinical trials.
• Strategies include participant compensation, independent consent, and conflict of interest disclosure.
• Severe financial conflicts may necessitate physician non-participation in trials.